CPRX
Catalyst Pharmaceuticals Inc
31.50$
+0.0%
vs. previous close
Closing price · As of: Jul 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.0% | – | 99.2% | 97.7% | 99.8% | 99.1% | 99.0% | 99.0% | 99.0% | 99.7% | 99.6% | 99.8% | 99.8% | 99.7% | 99.4% | 99.8% | 91.3% | 99.1% | 82.8% | 88.4% | 85.4% | 46.7% | 73.2% | 80.8% | |
| 96.0% | – | 99.2% | 97.7% | 99.1% | 95.6% | 97.8% | 97.7% | 93.9% | 96.5% | 8.4% | 8.7% | 20.7% | 47.0% | 33.3% | 67.3% | 27.4% | 79.7% | 67.7% | 72.1% | 79.4% | 29.3% | 60.8% | 64.1% | |
| 96.0% | – | 99.2% | 97.7% | 99.1% | 95.6% | 97.8% | 97.7% | 93.9% | 96.5% | 91.8% | 93.5% | 89.4% | 97.2% | 96.9% | 98.4% | 88.5% | 84.1% | 72.9% | 80.4% | 79.4% | 29.3% | 60.8% | 64.1% | |
| – | – | – | – | 0.4% | 0.4% | 0.1% | – | 2.3% | – | – | – | 8.0% | – | – | – | – | 9.4% | 3.1% | 2.8% | 2.9% | 11.4% | 7.7% | 11.6% | |
| – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 1.7% | 2.4% | 3.3% | 1.8% | 3.3% | 2.3% | 3.4% | |
| – | – | 0.5% | 0.5% | 0.1% | 0.8% | 0.8% | 0.9% | 0.8% | 0.2% | 0.3% | 0.2% | 0.2% | 0.3% | 0.6% | 0.2% | 0.4% | 0.2% | 0.1% | 1.7% | 0.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | 8.6% | 41.3% | 18.4% | 11.9% | |
| 59.8% | – | 36.6% | 43.4% | 3.7% | 2.1% | 12.2% | 4.4% | 5.4% | 39.8% | 12.9% | 15.7% | 19.7% | 7.7% | 5.7% | 5.2% | 16.0% | 22.0% | 11.8% | 13.0% | 20.0% | 17.5% | 14.5% | 13.8% | |
| – | – | 36.6% | 43.4% | 3.7% | 1.8% | 11.9% | 3.7% | 5.1% | 13.3% | 9.8% | 8.4% | 13.3% | 5.7% | 5.0% | 5.0% | 15.7% | 21.4% | 11.8% | 11.4% | 15.3% | 16.2% | 14.2% | 13.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.3% | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | |
| – | – | 16.6% | 8.6% | 2.2% | 1.3% | 2.8% | 3.1% | 1.8% | 4.2% | 8.1% | 3.4% | 4.1% | 3.0% | 2.2% | 2.3% | 3.9% | 3.7% | 2.2% | 1.2% | 1.1% | 3.1% | 1.9% | 1.0% | |
| – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 40.2% | – | 63.4% | 56.6% | 96.3% | 97.9% | 87.8% | 95.6% | 94.6% | 60.2% | 87.1% | 84.3% | 80.3% | 92.3% | 94.3% | 94.8% | 84.0% | 78.0% | 88.2% | 87.0% | 80.0% | 82.5% | 85.5% | 86.2% | |
| – | – | -660.5% | -383.8% | -27.9% | -59.3% | -170.1% | -347.8% | -543.8% | -609.7% | -251.2% | -214.2% | -159.1% | -149.9% | -259.3% | -148.2% | -265.6% | -114.5% | -27.9% | -11.1% | 13.3% | 25.8% | 33.5% | 42.8% | |
| 2,113.8% | – | 1,574.3% | 786.0% | 37.3% | 75.1% | 108.1% | 189.1% | 318.6% | 347.7% | 178.9% | 179.2% | 146.1% | 134.5% | 198.7% | 100.5% | 169.8% | 94.3% | 55.2% | 45.3% | 29.7% | 24.2% | 14.7% | 11.5% |
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.